Home
Scholarly Works
PHASE II RANDOMIZED TRIAL OF OPTIMAL...
Conference

PHASE II RANDOMIZED TRIAL OF OPTIMAL RECURRENCE-DIRECTED THERAPY (RDT) WITHOUT OR WITH ANDROGEN-DEPRIVATION THERAPY (ADT) IN RADIO-RECURRENT OLIGO-METASTATIC HORMONE/CASTRATE SENSITIVE PROSTATE CANCER (ROMCSPC): THE OCOG-RATIONAL-PCS TRIAL

Authors

Gouveia A; Vavassis P; Mesci A; Hotte S; Berlin A; Zukotynski K; Morgan S; Dayes I; Perlis N; Wright J

Volume

198

Pagination

pp. S54-S55

Publisher

ELSEVIER IRELAND LTD

Publication Date

September 1, 2024

Name of conference

Annual Scientific Meeting Interprofessional Collaboration: Better Together - Canadian-Association-of-Radiation-Oncology/ (CARO)

Conference place

CANADA, Vancouver

Conference start date

September 11, 2024

Conference end date

September 14, 2024

Conference proceedings

RADIOTHERAPY AND ONCOLOGY

ISSN

0167-8140

Contact the Experts team